NEIGHBOURS CALLING:      Dubai      Malaysia     Nepal     Bhutan
  HOME       Contact Us      Hire Us       Domestic Airlines        Railway Enquiry     Railway Booking     Hotels Abroad
indiatraveltimes.com
CORONAVIRUS CASUALTIES (July 3):- GLOBAL:- Total Cases: 1,10,53,545; Total Deaths: 5,25,410 Recovered: 61,91,434 BELGIUM:- Total Cases: 61,727; Total Deaths: 9,765 BRAZIL:- Total Cases: 15,02,424; Total deaths: 62,045 CANADA:- Total Cases: 104,936; Total Deaths: 8,644 CHINA:- Total Cases: 83,542 ; Total Deaths: 4,635 FRANCE:- Total Cases: 1,66,378; Total Deaths: 29,875 GERMANY:- Total Cases: 196,738; Total Deaths: 9,064 INDIA:- Total Cases: 6,33,381; Total Deaths: 18,320 INDONESIA:- Total Cases: 60,695; Total Deaths: 3,036 IRAN:- Total Cases: 2,35,429; Total Deaths: 11,260 ITALY:- Total Cases: 2,40,961; Total Deaths: 34,818 JAPAN:- Total Cases: 18,874 ; Total Deaths: 975 MEXICO:- Total Cases: 2,38,511; Total Deaths: 29,189 NETHERLANDS:- Total Cases: 50,335; Total Deaths: 6,113 PHILIPPINES:- Total Cases: 40,336; Total Deaths: 1,280 RUSSIA:- Total Cases: 6,67,883; Total Deaths: 9,859 S KOREA:- Total Cases: 12,967; Total Deaths: 282 SPAIN:-Total Cases: 2,97,183; Total Deaths: 28,368 SWEDEN:- Total Cases: 70,639; Total Deaths: 5,411 SWITZERLAND:-Total Cases: 32,101; Total Deaths: 1,965 UAE:- Total Cases: 49,469; Total Deaths:317 UK:- Total Cases: 2,83,757; Total Deaths: 43,995 US:- Total Cases: 28,54,976; Total Deaths: 1,31,663 - India Travel Times.Com   [Estd: 1998]       * * *    Travel, More Travel, Travel Means A Million Things     * * *    

When famotidine went out of stock in US, and Remdesivir is yet to deliver!

The US scientists picked up the lead from a reported Chinese finding that some elderly people who were routinely taking famotidine survived coronavirus infection. No sooner than Feinstein Institutes for Medical Research at Northwell Health, New York, said that their trial was nearing completion and they were hopeful, the antacid, already ruling high after the zantac debacle and appearing on the FDA short list, now again disappeared from the pharma shelves for a second time.

NEW DELHI, May 8: Helpless in the absence of a medicine to beat the new viral infection engulfing the world like a firestorm, people are ready to consume anything that the rumour mills are churning out for coronavirus (covid). Even scientists and doctors are trying to repurpose various existing medicines, throwing to the winds even the basic norms and ethics that govern the practice of science and medicine. They were trained in the nursery how not to see anything that is not on the table and not to make guineapigs of innocent human beings. With the result, till the other day it used to take anything around 20 years for a vaccine or drug to be pushed into the market.

Now with the outbreak of the new coronavirus that has made the whole world its killing field, repurposing existing drugs and finding host-based management like vaccines and plasma treatment in month's time is justifiably the order of the day.

In India, lopinavir-ritonavir, hydroxychloroquine, mycobacterium, disulfiram, resveratrol, remdesivir, plasma therapy have reportedly been tried to face the rapidly evolving challenge of a global emergency.

In the US, when the epidemic started sweeping the country by the middle of March, many experts and others suggested all sorts of remedies and drugs. Research was put on fast-forward for virus-targeted as well as host-based solutions. That was when even the President himself batted for hydroxychloroquine and in turn received brickbats from his political enemies that the realtor was canvassing business for a European pharma firm which proved otherwise when he purchased his own prescription drug from India in bulk after cajoling Modi into sharing some stocks.

Then came Gilead's repurposing drug, Remdesivir, which they projected as a breakout success. After much discussion at the White House and FDA approval, now there is a pause! It has started production although it is still described as in experimental stage. Japan has approved the drug with that limitation.

After hydroxychloroquine and remdesivir now comes the news that researchers at Feinstein Institutes for Medical Research at Northwell Health, New Hyde Park, New York, are in the final stage of declaring the efficacy of the simple famotidine, administered in intravenous doses to over a 1,000 coronavirus patients in trial since April 7. And the pepcid stocks have now disappeared from pharma shelves!

The hint for the US scientists had come from a reported Chinese finding that some elederly people who were taking routinely famotidine survived the viral attack. It would not occur to the Chinese that the other way round could also have been a possibility.

All said and done, coronavirus is not taking down the global economy, at least for the health sector.





Previous Files


Custom Search